Cargando…
The molecular basis of antimalarial drug resistance in Plasmodium vivax
Plasmodium vivax is the most geographically widespread cause of human malaria and is responsible for the majority of cases outside of the African continent. While great progress has been made towards eliminating human malaria, drug resistant parasite strains pose a threat towards continued progress....
Autores principales: | Buyon, Lucas E., Elsworth, Brendan, Duraisingh, Manoj T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113647/ https://www.ncbi.nlm.nih.gov/pubmed/33957488 http://dx.doi.org/10.1016/j.ijpddr.2021.04.002 |
Ejemplares similares
-
Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia
por: Marfurt, Jutta, et al.
Publicado: (2021) -
Transmission of Artemisinin-Resistant Malaria Parasites to Mosquitoes under Antimalarial Drug Pressure
por: Witmer, Kathrin, et al.
Publicado: (2020) -
Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions
por: Ferreira, Marcelo U., et al.
Publicado: (2020) -
Expression of Plasmodium vivax
crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility
por: Pava, Zuleima, et al.
Publicado: (2015) -
Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers
por: Brem, Jürgen, et al.
Publicado: (2015)